Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Fink

Showing results (21-30 of 165) with videos related to

Pageof 17
Sort By:
Critical Care Medicine|June 1, 1995
Another negative clinical trial of a new agent for the treatment of sepsis: rethinking the process of developing adjuvant treatments for serious infectionsM P Fink
Critical Care Medicine|June 1, 1997
The flow-directed, pulmonary artery catheter and outcome in critically ill patients: have we heard the last word?M P Fink
Intensive Care Medicine|May 1, 1997
Interpreting dual-sugar absorption studies in critically ill patients: what are the implications of apparent increases in intestinal permeability to hydrophilic solutes?M P Fink
Minerva Anestesiologica|August 31, 2000
Cytopathic hypoxia. A concept to explain organ dysfunction in sepsisM P Fink
Critical Care Medicine|July 11, 1998
On hemoglobin, hemorrhage, hypotension, and ... nitric oxideM P Fink
Critical Care Medicine|May 25, 2001
Exogenous administration of endogenous compounds: an emerging drug-development strategy in critical care pharmacologyM P Fink
Minerva Anestesiologica|May 29, 2001
Ringer's ethyl pyruvate solution: a novel resuscitation fluidM P Fink
Minerva Anestesiologica|May 29, 2001
Cytopathic hypoxia in sepsis: a true problem?M P Fink
Seminars in Respiratory Infections|December 1, 1994
Effect of critical illness on microbial translocation and gastrointestinal mucosa permeabilityM P Fink
Journal of Internal Medicine|March 30, 2007
Ethyl pyruvate: a novel anti-inflammatory agentM P Fink
Pageof 17

Showing results (21-30 of 165) with videos related to

Sort By:
Pageof 17
Critical Care Medicine|June 1, 1995
Another negative clinical trial of a new agent for the treatment of sepsis: rethinking the process of developing adjuvant treatments for serious infectionsM P Fink
Critical Care Medicine|June 1, 1997
The flow-directed, pulmonary artery catheter and outcome in critically ill patients: have we heard the last word?M P Fink
Intensive Care Medicine|May 1, 1997
Interpreting dual-sugar absorption studies in critically ill patients: what are the implications of apparent increases in intestinal permeability to hydrophilic solutes?M P Fink
Minerva Anestesiologica|August 31, 2000
Cytopathic hypoxia. A concept to explain organ dysfunction in sepsisM P Fink
Critical Care Medicine|July 11, 1998
On hemoglobin, hemorrhage, hypotension, and ... nitric oxideM P Fink
Critical Care Medicine|May 25, 2001
Exogenous administration of endogenous compounds: an emerging drug-development strategy in critical care pharmacologyM P Fink
Minerva Anestesiologica|May 29, 2001
Ringer's ethyl pyruvate solution: a novel resuscitation fluidM P Fink
Minerva Anestesiologica|May 29, 2001
Cytopathic hypoxia in sepsis: a true problem?M P Fink
Seminars in Respiratory Infections|December 1, 1994
Effect of critical illness on microbial translocation and gastrointestinal mucosa permeabilityM P Fink
Journal of Internal Medicine|March 30, 2007
Ethyl pyruvate: a novel anti-inflammatory agentM P Fink
Pageof 17